Only a few NVS locations are involved in drug discovery per se (as opposed to such functions as toxicology and formulation), and the Cambridge, MA site does a large portion of the drug-discovery work for the entire company. The salient point here is that NVS is not employing a business model that relies heavily on outsourcing of basic research.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”